First Affiliated Hospital Of Fujian Medical University
Clinical trials sponsored by First Affiliated Hospital Of Fujian Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New Scan-Guided biopsy could catch hidden prostate cancers Results expected Sep 2026 (estimated)
- AI reads CT scans to match kidney cancer patients with targeted drug Results expected Sep 2026 (estimated)
- Sound waves aim to tame Huntington's tremors Results expected Oct 2026 (estimated)
- Can targeted brain zaps ease movement problems in a rare ataxia? Results expected Nov 2026 (estimated)
- Targeted radiation zaps Hard-to-Treat prostate cancer in early trial Results expected Dec 2026 (estimated)
-
First-in-Human trial launches for targeted radiation therapy against FAP-Expressing tumors
Disease control OngoingThis study tests a new radioactive drug called 177Lu-JH040182 in people with advanced cancers that have a protein called FAP on their cells. The drug is designed to deliver radiation directly to the tumor. The main goals are to check safety and measure how much radiation reaches …
Phase 1 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New radioactive therapy shows promise for tough prostate cancer
Disease control OngoingThis study tests a low dose of a radioactive drug called 225Ac-LNC1011 in 16 men with a type of advanced prostate cancer that has stopped responding to hormone therapy. The drug targets a protein on cancer cells to deliver radiation directly. The goal is to see if it safely shrin…
Phase 1/2 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Blood test may catch kidney cancer sooner, study hints
Diagnosis OngoingThis study looks at whether measuring certain autoantibodies in the blood can help diagnose kidney cancer earlier and predict how the disease will progress. Researchers will analyze data from 400 patients to build a predictive model. The goal is to personalize treatment and avoid…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 26, 2026 17:40 UTC
-
Looking back to see ahead: study aims to spot CJD faster
Knowledge-focused By invitation onlyThis study looks back at the medical records of 150 people diagnosed with Creutzfeldt-Jakob disease (CJD), a rare and fast-moving brain disorder. Researchers will examine symptoms, blood tests, spinal fluid, brain scans, and EEG results to find patterns that could help doctors di…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
AI reads CT scans to match kidney cancer patients with targeted drug
Knowledge-focused OngoingThis study looks at 500 kidney cancer patients to see if CT scans and machine learning can predict levels of a protein called HIF-2α. The goal is to better identify which patients might benefit from a targeted drug called Belzutifan, reducing unnecessary treatments and improving …
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC